全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Edwards Brian
来源:[J].Drug Safety(IF 3.408), 2004, Vol.27 (8), pp.609-17PubMed
摘要:The pharmaceutical industry is under pressure to improve the scientific quality of its decisions concerning the benefit and risks of its products while ensuring compliance with acceptable standards of marketing. All those in a pharmaceutical company who currently work within phar...
作者:McKoy June M , Lyons E Allison , Obadina Eniola ...
来源:[J].Journal of Clinical Oncology(IF 18.038), 2005, Vol.23 (34), pp.8894-905PubMed
摘要:In the course of recent health care fraud investigations against TAP Pharmaceuticals (Lake Forest, IL) and AstraZeneca International (London, United Kingdom), each pled guilty to one violation of the Prescription Drug Marketing Act, settled claims related to alleged violations of...
作者:Tuthill Cynthia
来源:[J].New York Academy of Sciences. Annals(IF 4.375), 2007, Vol.1112, pp.351-6PubMed
摘要:SciClone Pharmaceuticals licensed the commercial and patent rights to thymosin alpha1, for geographical regions of the world excluding the United States and Europe, in the early 1990s. With this license, SciClone embarked on global drug development, and the issues encountered for...
作者:Alastair Matheson
来源:[J].BMC Medical Ethics(IF 1.705), 2016, Vol.17 (1)Springer
摘要:... Together, these weaknesses facilitate “advocacy”-based marketing, in which literature planned, financed and produced by companies is fronted by academics, enabling commercial messages to be presented to customers by their respected clinical peers rather than companies ...
作者:Zalesky Christopher D
来源:[J].Journal of health law, 2006, Vol.39 (2), pp.235-64PubMed
摘要:Fraudulent or abusive sales and marketing practices by pharmaceutical companies can result in costly overutilization of products that are increasingly paid for by government healthcare programs and may result in adverse health and safety consequences to the patient-beneficiaries ...
作者:Cardarelli Roberto , Licciardone John C , Taylor Lockwood G
来源:[J].BMC Family Practice(IF 1.609), 2006, Vol.7, pp.13PubMed
摘要:A major marketing technique used by pharmaceutical companies is direct-to-physician marketing. This form of marketing frequently employs promotional marketing brochures, based on clinical research, which may influence how a physician prescribes medicines. This study's objective w...
作者:Mahrukh Mohiuddin , Sabina Faiz Rashid , Mofijul Islam Shuvro ...
来源:[J].BMC Medical Ethics(IF 1.705), 2015, Vol.16 (1)Springer
摘要:Abstract(#br) Background(#br)The pharmaceutical market in Bangladesh is highly concentrated (top ten control around 70 % of the market). Due to high competition aggressive marketing strategies are adopted for greater market share, which sometimes cross limit. There is lack of...
作者:Hollon Matthew F
来源:[J].CNS Drugs(IF 4.826), 2004, Vol.18 (2), pp.69-77PubMed
摘要:In the US and New Zealand, the past decade has seen tremendous growth in the marketing of prescription drugs directly to patients. The pharmaceutical industry has applied pressure in other countries to relax regulations governing such marketing although this has not yet been succ...
作者:Campo Katia , De Staebel Odette , Gijsbrechts Els ...
来源:[J].Health Marketing Quarterly, 2006, Vol.22 (4), pp.73-107PubMed
摘要:... Several interesting findings emerge from the analysis: (i) non-compensatory decision rules seem to dominate the decision process, (ii) consideration sets are typically small and change-resistant, (iii) drug cost is not a major issue for most physicians, (iv) detailing remains one of the most powerful pharmaceutical marketing...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×